Therapeutic Advances in Drug Safety
| 短名 | Ther. Adv. Drug. Saf. |
| Journal Impact | 3.21 |
| 国际分区 | PHARMACOLOGY & PHARMACY(Q2) |
| 期刊索引 | SCI Q2中科院 3 区 |
| ISSN | 2042-0986, 2042-0994 |
| h-index | 46 |
| 国内分区 | 医学(3区)医学药学(2区) |
THERAPEUTIC ADVANCES IN DRUG SAFETY 就与患者安全使用药物有关的开创性努力和创新研究提供最高质量的同行评议文章、评论和学术评论。该杂志具有很强的临床和药理学重点，面向临床医生和药物安全研究人员，提供印刷和在线论坛，以发表该领域最高质量的文章。编辑欢迎有关药物安全所有领域研究的当前感兴趣的文章，包括治疗药物监测、药物流行病学、药物不良反应、药物相互作用、药代动力学、药物警戒、药物/处方错误、风险管理、伦理和监管。
期刊主页| 涉及主题 | 医学生物内科学药理学心理学精神科病理重症监护医学不利影响化学外科政治学法学护理部数学药品生物化学统计经济遗传学家庭医学内分泌学 |
| 出版信息 | 出版商: SAGE Publications Ltd，出版周期: ，期刊类型: journal |
| 基本数据 | 创刊年份: 2010，原创研究文献占比: 66.67%，自引率:5.90%， Gold OA占比: 94.38% |
| 平均审稿周期 | 网友分享经验：9 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Characterizing medication safety incidents in surgical patients: a retrospective cross-sectional analysis of incident reports
2024-1-1
Pirfenidone-induced liver injury, a case report of a rare idiosyncratic reaction
2024-1-1
The 7th European Pharmacovigilance Congress: speaker abstracts
2024-1-1
Drug–drug interaction between tacrolimus and caspofungin in Chinese kidney transplant patients with different <i>CYP3A5</i> genotypes
2024-1-1
Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database
2024-1-1
Short-term prognosis of polypharmacy in elderly patients treated in emergency departments: results from the EDEN project
2024-1-1
Medication errors by caregivers in the homes of children discharged from a pediatric department in Ghana
2024-1-1
Evaluation of early retinal changes in patients on long-term hydroxychloroquine using optical coherence tomography angiography
2024-1-1
Expression of Concern
2024-1-1
The crucial role of pharmacovigilance in managing infectious diseases in lower and middle-income countries
2024-1-1
Oxaliplatin-associated shock in stage III colorectal cancer patients: real-world evidence in Taiwan
2024-1-1
Interventions and impact of pharmacist-delivered services in perioperative setting on clinically important outcomes: a systematic review and meta-analysis
2024-1-1
Olanzapine for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a randomized controlled trial
2024-1-1
Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021
2024-1-1
Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study
2024-1-1
Structured medication reviews in Parkinson’s disease: pharmacists’ views, experiences and needs – a qualitative study
2024-1-1
Determinants of COVID-19 vaccine-induced myocarditis
2024-1-1
Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation
2024-1-1
Anticholinergic burden among in-patients: a cross-sectional study on prevalence, determinants, and impact on mortality in Ethiopia
2024-1-1
Effect of heparin for the prevention of venous thromboembolism in patients with spontaneous intracranial cerebral hemorrhage: a meta-analysis
2024-1-1
The American Program in Pharmacovigilance (Am2P): a new accredited online training program in pharmacovigilance and pharmacoepidemiology
2024-1-1
A retrospective pharmacovigilance study of post-marketing safety concerns with cefuroxime
2024-1-1
Vonoprazan-associated <i>Clostridioides difficile</i> infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System
2024-1-1
Fetal exposure to isotretinoin in Saudi Arabia: a multicenter real-world data analysis from 2015 to 2020
2024-1-1
Adverse event profiles of drug-induced liver injury caused by antidepressant drugs: a disproportionality analysis
2024-1-1
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review
2024-1-1
Association of thrombopoietin-related drugs with thromboembolic events: Mendelian randomization and a real-world study
2024-1-1
Inappropriate quetiapine use at a large academic medical center: frequency of misuse and associated costs of adverse effects
2023-1-1
Analysis of the nature and contributory factors of medication safety incidents following hospital discharge using National Reporting and Learning System (NRLS) data from England and Wales: a multi-method study
2023-1-1
Acceptability of a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice: a mixed methods study
2023-1-1
Impact of risk communication on patient’s safety during the pandemic
2023-1-1
Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey
2023-1-1
Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature
2023-1-1
Flow rate accuracy of infusion devices within healthcare settings: a systematic review
2023-1-1
Safety monitoring of oral iron supplements in pregnant women with anemia: a multi-center observational clinical study
2023-1-1
HIV/AIDS patients’ knowledge, attitude, and practice toward anti-retroviral therapy medications’ adverse effects and associated factors in Tikur Anbessa Specialized Hospital
2023-1-1
The 6th European Pharmacovigilance Congress: speaker abstracts
2023-1-1
Hospital admissions attributed to adverse drug reactions in tertiary care in Uganda: burden and contributing factors
2023-1-1
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study
2023-1-1
Evaluation of four machine learning models for signal detection
2023-1-1
Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy
2023-1-1
Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community
2023-1-1
Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature
2023-1-1
Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries
2023-1-1
Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review
2023-1-1
Risk of lower limb amputation in diabetic patients using SGLT2 inhibitors <i>versus</i> DPP4 inhibitors or GLP-1 agonists: a meta-analysis of 2 million patients
2023-1-1
Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database
2023-1-1
Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers
2023-1-1
Modified Dixon sequential method to determine the effective dose of alfentanil compounded with propofol for day-case hysteroscopy
2023-1-1
Physiologically based pharmacokinetic modeling of candesartan to predict the exposure in hepatic and renal impairment and elderly populations
2023-1-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远